EcoR1 Capital, LLC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:01 pm Sale | 2024-09-30 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital, LLC | 0 0.000% | -6,117,400 (Position Closed) | Filing |
| 2023-02-10 2:28 pm Purchase | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital, LLC | 6,117,400 8.700% | 35,200 (+0.58%) | Filing |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital, LLC | 6,082,200 8.900% | 6,082,200 (New Position) | Filing |